US 2020/0345652 A1 · Nanopore Delivery Device

Abstract

The invention relates to an implantable device to deliver drug formulations through a nanoporous membrane. The current related arts for delivery of drug formulations include tablets, injections, implantable pellets, injectable polymer depots, and implantable infusion pumps. The invention employs a reservoir to contain the drug formulation, a nanoporous membrane, and a formulation of buprenorphine.

Claims26

Dependent claims

An implantable sustained release buprenorphine delivery device comprising:

a reservoir housing;
a nanoporous membrane:
a formulation of buprenorphine.

Dependencies are inferred from the claim text.

Facts

Application

16/862,723Filed 30 Apr 2020

Priority

3 May 2019

Published

5 Nov 2020

Term ends

Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 9/7007
Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug: drug-containing films, membranes or sheets
A61K 9/0024
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in…
A61K 31/485
Quinolines; Isoquinolines: morphinan derivatives, e.g. morphine, codeine
B82Y 5/00
Nanobiotechnology or nanomedicine

Abstract

Claims26

Dependent claims

An implantable sustained release buprenorphine delivery device comprising:

a reservoir housing;
a nanoporous membrane:
a formulation of buprenorphine.

Dependencies are inferred from the claim text.

Nanopore Delivery Device

Life of this patent

Abstract

Claims26

Nanopore Delivery Device

Life of this patent

Abstract

Claims26